These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 1839076)

  • 1. [H-B-VAX II hepatitis B vaccine (recombinant) produced at the MSD Research Laboratories. Description of the vaccine].
    Przegl Epidemiol; 1991; 45(1-2):3-10. PubMed ID: 1839076
    [No Abstract]   [Full Text] [Related]  

  • 2. [H-B-VAX II].
    Pol Tyg Lek; 1990 Sep 17-24; 45(38-39):801-4. PubMed ID: 2095552
    [No Abstract]   [Full Text] [Related]  

  • 3. [Humoral response in health service personnel after administration of hepatitis B vaccine Gen-H-B-Vax].
    Juszczyk J; Rokossowski H; Krajewska M; Piatek A
    Przegl Epidemiol; 1991; 45(1-2):11-6. PubMed ID: 1839075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dose of hepatitis B vaccine.
    Seville P
    N Z Med J; 1988 Nov; 101(857):774. PubMed ID: 2972946
    [No Abstract]   [Full Text] [Related]  

  • 5. Low dose hepatitis B vaccination in children: benefit of low dose boosters.
    Milne A; Moyes CD; Dimitrakakis M
    N Z Med J; 1988 Jun; 101(847 Pt 1):370-1. PubMed ID: 2970604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Active preventive vaccination against hepatitis B].
    Jilg W
    Internist (Berl); 1985 Oct; 26(10):633-9. PubMed ID: 2934346
    [No Abstract]   [Full Text] [Related]  

  • 7. Mass vaccination against hepatitis B in preschool children: immunogenicity after three reduced doses.
    Milne A; Moyes CD; Waldon J; Pearce NE; Krugman S
    N Z Med J; 1989 Aug; 102(874):429-30. PubMed ID: 2527346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of viral hepatitis B in early infancy--hepatitis B vaccine (HBVac)].
    Tanabe M; Noguchi H; Tsuzuki K; Minowa S; Tsuyuki M; Tsuji A; Itoh S; Kanoh H; Katoh T; Mizokami M
    Nagoya J Med Sci; 1984 Mar; 46(1-4):49-54. PubMed ID: 6234469
    [No Abstract]   [Full Text] [Related]  

  • 9. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
    Frazer IH; Jones B; Dimitrakakis M; Mackay IR
    Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Course of antibody titer following preventive hepatitis B vaccination and a recommendation for renewal following the use of H-B-Vax vaccines].
    Kätzner K; Kalitzky M; Steinhagen-Thiessen E; Gatermann S; Laufs R
    Z Gastroenterol; 1985 Jan; 23(1):18-24. PubMed ID: 2932862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.
    Frey S; Dagan R; Ashur Y; Chen XQ; Ibarra J; Kollaritsch H; Mazur MH; Poland GA; Reisinger K; Walter E; Van Damme P; Braconier JH; Uhnoo I; Wahl M; Blatter MM; Clements D; Greenberg D; Jacobson RM; Norrby SR; Rowe M; Shouval D; Simmons SS; van Hattum J; Wennerholm S; Gress JO
    J Infect Dis; 1999 Dec; 180(6):2018-22. PubMed ID: 10558961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vaccination against hepatitis virus B infection. Vaccine from inactivated HBsAg positive plasma or recombinant vaccine?].
    Horejsí J
    Cas Lek Cesk; 1987 Jul; 126(31):981-2. PubMed ID: 2959363
    [No Abstract]   [Full Text] [Related]  

  • 14. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
    Romanò L; Biffi R; Bianchi S; Zanetti A
    Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant yeast hepatitis B vaccine.
    Hilleman MR
    Dev Biol Stand; 1986; 63():57-62. PubMed ID: 3527821
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant hepatitis B vaccine.
    Med Lett Drugs Ther; 1986 Dec; 28(728):118-9. PubMed ID: 2946924
    [No Abstract]   [Full Text] [Related]  

  • 17. Developments in immunization against hepatitis B.
    Zuckerman AJ
    Ann Ist Super Sanita; 1987; 24(2):285-91. PubMed ID: 2969206
    [No Abstract]   [Full Text] [Related]  

  • 18. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Respective importance of vertical and horizontal transmission of hepatitis B in the Australian archipelago (French Polynesia). Preliminary results of the vaccination of newborns].
    Boutin JP; Spiegel A; Flye Sainte-Marie F; Cartel JL; Girard M; Saliou P; Roux J
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):906-11. PubMed ID: 1840244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of pre-S gene products in HBsAg carriers and in hepatitis B vaccines].
    Gerken G; Manns M; Kyriatsoulis A; Hess G; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1988 Jul; 26(7):374-9. PubMed ID: 2851893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.